Synergistic deposition of C4d by complement-activating and non-activating antibodies in cardiac transplants

American Journal of Transplantation

Volumn 7, Issue 11, 2007, Pages 2605-2614

  Murata, K ^a   Fox Talbot, K ^a   Qian, Z ^a   Takahashi, K ^b   Stahl, G L ^c   Baldwin III, W M ^a   Wasowska, B A ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Alloantibodies; Allograft; Antibody mediated rejection; C4d; MBL

Indexed keywords

ALLOANTIBODY; ANTIBODY; COMPLEMENT COMPONENT C4D; IMMUNOGLOBULIN; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MANNOSE BINDING LECTIN;

ALLOGRAFT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; INCUBATION TIME; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ANIMALS; COMPLEMENT ACTIVATION; COMPLEMENT C4B; COMPLEMENT SYSTEM PROTEINS; FLOW CYTOMETRY; HEART TRANSPLANTATION; HUMANS; ISOANTIBODIES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MODELS, ANIMAL; PEPTIDE FRAGMENTS; RABBITS; TRANSPLANTATION, HOMOLOGOUS;

EID: 35248823071     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2007.01971.x     Document Type: Article

References (49)

1. Michaels PJ, Fishbein MC, Colvin RB. Humoral rejection of human organ transplants. Springer Semin Immunopathol 2003 25 : 119 140.
2. Feucht HE, Felber E, Gokel MJ et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol 1991 86 : 464 470.
3. Mauiyyedi S, Colvin RB. Humoral rejection in kidney transplantation: New concepts in diagnosis and treatment. Curr Opin Nephrol Hypertens 2002 11 : 609 618.
4. Mauiyyedi S, Crespo M, Collins AB et al. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification. J Am Soc Nephrol 2002 13 : 779 787.
5. Uretsky BF, Murali S, Reddy PS et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987 76 : 827 834.
6. Feucht HE. Complement C4d in graft capillaries - the missing link in the recognition of humoral alloreactivity. Am J Transplant 2003 3 : 646 652.
7. Qian Z, Lee C, Murata K et al. Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion. Transplantation 2006 2006 : 857 864.
8. Minami K, Murata K, Lee CY et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 2006 6 (5 Pt 1 923 932.
9. Rahimi S, Qian Z, Layton J, Fox-Talbot K, Baldwin WM, 3rd., Wasowska BA. Non-complement- and complement-activating antibodies synergize to cause rejection of cardiac allografts. Am J Transplant 2004 4 : 326 334.
10. Wasowska BA, Qian Z, Cangello DL et al. Passive transfer of alloantibodies restores acute cardiac rejection in IgKO mice. Transplantation 2001 71 : 727 736.
11. Qian Z, Jakobs FM, Pfaff-Amesse T, Sanfilippo F, Baldwin WM, 3rd. Complement contributes to the rejection of complete and class I major histocompatibility complex-incompatible cardiac allografts. J Heart Lung Transplant 1998 17 : 470 478.
12. Nakashima S, Qian Z, Rahimi S, Wasowska BA, Baldwin WM, 3rd. Membrane attack complex contributes to destruction of vascular integrity in acute lung allograft rejection. J Immunol 2002 169 : 4620 4627.
13. Karuppan SS, Ohlman S, Moller E. The occurrence of cytotoxic and non-complement-fixing antibodies in the crossmatch serum of patients with early acute rejection episodes. Transplantation 1992 54 : 839 844.
14. Arnold ML, Zacher T, Dechant M, Kalden JR, Doxiadis, II., Spriewald BM. Detection and specification of non-complement binding anti-HLA alloantibodies. Hum Immunol 2004 65 : 1288 1296.
15. Kushihata F, Watanabe J, Mulder A, Claas F, Scornik JC. Human leukocyte antigen antibodies and human complement activation: Role of IgG subclass, specificity, and cytotoxic potential. Transplantation 2004 78 : 995 1001.
16. Wahrmann M, Exner M, Schillinger M et al. Pivotal role of complement-fixing HLA alloantibodies in presensitized kidney allograft recipients. Am J Transplant 2006 6 (5 Pt 1 1033 1041.
17. Anderson WH, Stroud RM. Generation and enrichment of C4d in whole serum. J Immunol Methods 1979 29 : 323 330.
18. Ozato K, Mayer N, Sachs DH. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 1980 124 : 533 540.
19. Burdick JF, Clow LW. Rejection of murine cardiac allografts. I. Relative roles of major and minor antigens. Transplantation 1986 42 : 67 72.
20. Botto M, Dell'Agnola C, Bygrave AE et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998 19 : 56 59.
21. Shi L, Takahashi K, Dundee J et al. Mannose-binding lectin-deficient mice are susceptible to infection with Staphylococcus aureus. J Exp Med 2004 199 : 1379 1390.
22. Lemke H, Hammerling GJ. Clustering of antigenic determinants on H-2 molecules. J Immunol 1982 128 : 2465 2469.
23. McMullen ME, Hart ML, Walsh MC, Buras J, Takahashi K, Stahl GL. Mannose-binding lectin binds IgM to activate the lectin complement pathway in vitro and in vivo. Immunobiology 2006 211 : 759 766.
24. Chan RK, Ibrahim SI, Takahashi K et al. The differing roles of the classical and mannose-binding lectin complement pathways in the events following skeletal muscle ischemia-reperfusion. J Immunol 2006 177 : 8080 8085.
25. Malhotra R, Wormald MR, Rudd PM, Fischer PB, Dwek RA, Sim RB. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nature Medicine 1995 1 : 237 243.
26. Crespo-Leiro MG, Veiga-Barreiro A, Domenech N et al. Humoral heart rejection (severe allograft dysfunction with no signs of cellular rejection or ischemia): Incidence, management, and the value of C4d for diagnosis. Am J Transplant 2005 5 : 2560 2564.
27. Rodriguez ER, Skojec DV, Tan CD et al. Antibody-mediated rejection in human cardiac allografts: Evaluation of immunoglobulins and complement activation products C4d and C3d as markers. Am J Transplant 2005 5 : 2778 2785.
28. Smith RN, Brousaides N, Grazette L et al. C4d deposition in cardiac allografts correlates with alloantibody. J Heart Lung Transplant 2005 24 : 1202 1210.
29. Regele H, Exner M, Watschinger B et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 2001 16 : 2058 2066.
30. Mengel M, Bogers J, Bosmans JL et al. Incidence of C4d stain in protocol biopsies from renal allografts: Results from a multicenter trial. Am J Transplant 2005 5 : 1050 1056.
31. Fishbein MC, Kobashigawa J. Biopsy-negative cardiac transplant rejection: Etiology, diagnosis, and therapy. Curr Opin Cardiol 2004 19 : 166 169.
32. Takemoto SK, Zeevi A, Feng S et al. National conference to assess antibody-mediated rejection in solid organ transplantation. Am J Transplant 2004 4 : 1033 1041.
33. Bohmig GA, Exner M, Habicht A et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Soc Nephrol 2002 13 : 1091 1099.
34. Narayanan K, Naziruddin B, Phelan D, Mohanakumar T. Mechanism for in vitro "accommodation" of human aortic endothelial cells by alloantibodies specific for HLA molecules: Down regulation of adhesion molecules and over expression of protective genes. Hum Immunol 2002 63 (10 Suppl. S19.
35. Narayanan K, Jendrisak MD, Phelan DL, Mohanakumar T. HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway. Transpl Immunol 2006 15 : 187 197.
36. van de Winkel JG, Capel PJ. Human IgG Fc receptor heterogeneity: Molecular aspects and clinical implications. Immunol Today 1993 14 : 215 221.
37. Schmidt RE, Gessner JE. Fc receptors and their interaction with complement in autoimmunity. Immunol Lett 2005 100 : 56 67.
38. Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol 2001 19 : 275 290.
39. Jin YP, Jindra PT, Gong KW, Lepin EJ, Reed EF. Anti-HLA class I antibodies activate endothelial cells and promote chronic rejection. Transplantation 2005 79 (3 Suppl. S19 21.
40. Jin YP, Singh RP, Du ZY, Rajasekaran AK, Rozengurt E, Reed EF. Ligation of HLA class I molecules on endothelial cells induces phosphorylation of Src, paxillin, and focal adhesion kinase in an actin-dependent manner. J Immunol 2002 168 : 5415 5423.
41. Scornik JC, Clapp W, Patton PR et al. Outcome of kidney transplants in patients known to be flow cytometry crossmatch positive. Transplantation 2001 71 : 1098 1102.
42. Patel R, Terasaki PI. Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 1969 280 : 735 739.
43. Wahrmann M, Exner M, Regele H et al. Flow cytometry based detection of HLA alloantibody mediated classical complement activation. J Immunol Methods 2003 275 : 149.
44. Collins C, Tsui FW, Shulman MJ. Differential activation of human and guinea pig complement by pentameric and hexameric IgM. Eur J Immunol 2002 32 : 1802 1810.
45. Arnold JN, Wormald MR, Suter DM et al. Human serum IgM glycosylation: Identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem 2005 280 : 29080 29087.
46. Imai N, Nishi S, Alchi B et al. Immunohistochemical evidence of activated lectin pathway in kidney allografts with peritubular capillary C4d deposition. Nephrol Dial Transplant 2006 21 : 2589 2595.
47. Sund S, Hovig T, Reisaeter AV, Scott H, Bentdal O, Mollnes TE. Complement activation in early protocol kidney graft biopsies after living-donor transplantation. Transplantation 2003 75 : 1204 1213.
48. Berger SP, Roos A, Mallat MJ, Fujita T, de Fijter JW, Daha MR. Association between mannose-binding lectin levels and graft survival in kidney transplantation. Am J Transplant 2005 5 : 1361 1366.
49. Fiane AE, Ueland T, Simonsen S et al. Low mannose-binding lectin and increased complement activation correlate to allograft vasculopathy, ischaemia, and rejection after human heart transplantation. Eur Heart J 2005 26 : 1660 1665.